Pharmacists’ concerns regarding patient understanding of generic medicines and substitution, patient safety and compliance with treatments |
a. Patient confusion |
[14, 51–53, 56, 58] |
b. Concerns regarding interchangeability |
[13, 14, 51, 53, 54, 56, 58] |
c. Problems with patient compliance |
[13, 51, 53, 56] |
Pharmacists’ understanding of generic medicines and substitution, and pharmacists’ confidence in quality, efficacy and safety of generic medicines |
a. Level of confidence in knowledge |
[15, 53, 55, 56, 58] |
b. Hospital-based pharmacists versus community pharmacists |
[13] |
c. Need to contact prescriber |
[51] |
d. Belief that the patient prefers physician opinion |
[52, 53, 58] |
e. Requirement for adverse event reporting |
[54, 56] |
Practical aspects of pharmacists’ practice as affected by generic medicines and substitution |
a. Financial incentives by pharmaceutical industry |
[13, 15, 52, 56–58] |
b. Increased pharmacist workload |
[13, 51, 53, 54, 56, 58] |
c. Adverse effect on stocking levels |
[14, 51, 53] |
d. Influence of industry representatives |
[15, 52, 58] |
Pharmacists’ suggestions to improve generic medicine use and education of stakeholders |
a. General education needed |
[14, 15, 52–58] |
b. Patients should have a role in medication decision |
[51, 53] |
c. Need for change in prescribing patterns |
[52, 53, 57, 58] |